Z-1457-2017 Class II Terminated
FDA device recall Z-1457-2017 was initiated by Merge Healthcare, Inc. on Apr 4, 2016 and is designated Class II. Reason for recall: In some instances, the system will lock tabs within a study, even when a second user does not have the study open on a different workstation. The recall status is terminated (terminated Aug 5, 2019). Affected quantity: 361 sites potentially have the affected versions.
Recall details
- Product Type
- Devices
- Report Date
- Mar 22, 2017
- Initiation Date
- Apr 4, 2016
- Termination Date
- Aug 5, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 361 sites potentially have the affected versions
Product description
Merge Hemo software. Product Usage: Merge Hemo is a hemodynamic monitoring system that records and displays physiological data.
Reason for recall
In some instances, the system will lock tabs within a study, even when a second user does not have the study open on a different workstation.
Distribution pattern
US Nationwide Distribution.
Code information
Versions 6.10, 6.10.1, 6.10.2, 6.10.3, 7.10, 7.20, 7.20.1, 8.10.0, 8.20, 9.10.0, 9.20, 9.20.2, 9.20.3, 9.30, 9.40, 9.40.1, 9.40.2, and 9.40.3
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1457-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026